<ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
<p>Liquidia Corporation (NASDAQ:LQDA - 免费报告) - HC Wainwright 的研究分析师在 5 月 12 日向投资者发布的报告中上调了 Liquidia 2028 财年的每股收益（EPS）预期。HC Wainwright 分析师 A. Fein 现在预计该公司将实现每股收益 6.37 美元，高于之前预测的 5.93 美元。HC Wainwright 对该股票给予 &#34;买入&#34; 评级，目标价为 67.00 美元。Liquidia 当前全年的共识收益预期为每股 2.14 美元。HC Wainwright 还对 Liquidia 2030 财年的收益预期为每股 8.36 美元。</p>
<p>其他股票研究分析师最近也发布了关于该股票的研究报告。富国银行将 Liquidia 的目标价从 51.00 美元上调至 62.00 美元，并在周二的研究报告中给予公司 &#34;超配&#34; 评级。Lifesci Capital 在 3 月 5 日的报告中将 Liquidia 的评级上调至 &#34;强力买入&#34;。杰富瑞金融集团在周一的报告中重申了 &#34;买入&#34; 评级，并对 Liquidia 的股票设定了 60.00 美元的目标价。Oppenheimer 在 3 月 12 日的报告中将 Liquidia 的目标价从 16.00 美元上调至 19.00 美元，并给予该股票 &#34;表现不佳&#34; 的评级。最后，Zacks Research 在 5 月 5 日的报告中将 Liquidia 的评级从 &#34;持有&#34; 上调至 &#34;强力买入&#34;。三位投资分析师对该股票给予了强力买入评级，七位给予了买入评级，两位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 &#34;适度买入&#34;，共识目标价为 49.33 美元。</p>
<ul>
<li>Liquidia：法院胜利是行业巨头的觉醒？</li>
</ul>
<p><strong>获取我们最新的 Liquidia 股票报告</strong></p>
<h2>Liquidia 股价上涨 6.5%</h2>
<p>LQDA 的股票在周三以 56.60 美元开盘。该公司的市值为 50.3 亿美元，市盈率为 404.31，贝塔值为 0.41。该公司的速动比率为 1.84，流动比率为 2.01，债务与股本比率为 2.97。该公司的 50 日简单移动平均为 38.17 美元，200 日简单移动平均为 35.29 美元。Liquidia 的 12 个月低点为 11.85 美元，12 个月高点为 57.00 美元。</p>
<p>Liquidia (NASDAQ:LQDA - 获取免费报告) 最近在 5 月 11 日公布了季度财报。该公司报告季度每股收益为 0.52 美元，超出共识预期的 0.41 美元，超出幅度为 0.11 美元。该季度的营业收入为 1.3287 亿美元，而分析师预期为 1.1944 亿美元。Liquidia 的净利润率为 7.74%，股本回报率为 81.61%。与去年同期相比，该公司的收入增长了 4187.1%。</p>
<h2>内部人士下注</h2>
<p>在其他 Liquidia 的新闻中，首席财务官 Michael Kaseta 于 4 月 15 日出售了 139,390 股公司的股票。股票以平均价格 40.14 美元出售，总价值为 5,595,114.60 美元。交易完成后，首席财务官直接持有 353,356 股公司的股票，价值约为 14,183,709.84 美元。这代表其持股减少了 28.29%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，董事 Stephen M. Bloch 于 3 月 27 日出售了 62,550 股公司的股票。股票以平均价格 35.94 美元出售，总交易额为 2,248,047.00 美元。交易完成后，该董事持有 2,188,935 股公司的股票，价值 78,670,323.90 美元。此交易代表其持股减少了 2.78%。该出售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了价值 25,838,508 美元的 653,820 股公司股票。当前 25.60% 的股票由公司内部人士持有。</p>
<h2>机构资金流入和流出</h2>
<p>几家机构投资者最近调整了对 LQDA 的持股。Farallon Capital Management LLC 在第三季度将其在 Liquidia 的持股增加了 102.1%。Farallon Capital Management LLC 现在拥有 8,565,638 股公司股票，价值 194,783,000 美元，此前在上一季度增持了 4,326,876 股。TCG Crossover Management LLC 在第三季度购买了 Liquidia 的新头寸，价值约 38,887,000 美元。Caprock Group LLC 在第三季度购买了 Liquidia 的新头寸，价值约 37,114,000 美元。MPM Bioimpact LLC 在第四季度将其在 Liquidia 的持股增加了 600.4%。MPM Bioimpact LLC 现在拥有 1,400,869 股公司股票，价值 48,316,000 美元，此前增持了 1,200,869 股。最后，Voloridge Investment Management LLC 在第三季度购买了 Liquidia 的新头寸，价值约 12,571,000 美元。当前 64.54% 的股票由机构投资者持有。</p>
<h2>Liquidia 新闻汇总</h2>
<p>以下是本周影响 Liquidia 的主要新闻故事：</p>
<ul>
<li>积极情绪：Liquidia 报告了第一季度的重大超预期，每股收益为 0.52 美元，预期为 0.41 美元，收入为 1.3287 亿美元，预期为 1.1944 亿美元，进一步巩固了公司的快速商业增长和改善的盈利能力。财报</li>
<li>积极情绪：管理层表示 YUTREPIA 的净产品销售环比增长 44%，预计到 2027 年净收入至少达到 10 亿美元，显示出强劲的上市势头和长期的增长潜力。Seeking Alpha 文章</li>
<li>积极情绪：Needham 将其目标价上调至 70 美元，BTIG 将其目标价上调至 59 美元，均维持看涨评级，这表明华尔街在财报超预期后看到了更多的上涨空间。Needham 目标价说明</li>
<li>积极情绪：Zacks 将 Liquidia 纳入其强力买入名单，在财报发布后又增加了一次情绪提振。Zacks 强力买入名单</li>
<li>中性情绪：首席执行官 Roger Jeffs 在一项预先安排的 10b5-1 计划中出售了 25,000 股；虽然这值得注意，但与他剩余的股份相比，这似乎是例行的且相对较小。SEC 文件</li>
<li>消极情绪：最近的一次评级下调认为 YUTREPIA 的上市势头可能接近天花板，提出了关于市场份额扩展还有多少的疑问。Seeking Alpha 下调</li>
</ul>
<h2>Liquidia 公司简介</h2>
<p>(获取免费报告)</p>
<p>Liquidia Technologies, Inc 是一家临床阶段的生物制药公司，总部位于北卡罗来纳州的研究三角园区。该公司利用其专有的 PRINT®（非湿润模板中的颗粒复制）平台来工程化精确形状和尺寸的药物颗粒，旨在改善药物的递送、疗效和安全性。通过控制纳米尺度的颗粒特性，Liquidia 力求增强依赖于靶向递送的呼吸和其他疗法。</p>
<p>该公司的主要产品候选药物 LIQ861 是一种干粉配方的特雷普利斯汀，旨在用于治疗肺动脉高压（PAH）患者的吸入。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票</li>
<li>一笔真正的大交易：温迪汉堡推出丰厚的收购套利</li>
<li>Ally Financial 回归基础——投资者在关注</li>
<li>Navitas 在印度交易中突破，验证高功率 AI 转型</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Liquidia 吗？</h2>
<p>在考虑 Liquidia 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，建议在更广泛的市场注意到之前购买……而 Liquidia 并不在名单上。</p>
<p>虽然 Liquidia 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

LQDA

纳斯达克生物科技指数 ETF - iShares Nasdaq

标普全球医疗股指数 ETF - iShares

<p>Liquidia Corporation（纳斯达克代码：LQDA）在 2028 财年的每股收益（EPS）预期上升，HC Wainwright 将其预期提高至 6.37 美元，之前为 5.93 美元。该公司维持 “买入” 评级，目标价为 67.00 美元。其他分析师也提高了他们的目标价，富国银行将其目标价上调至 62.00 美元。Liquidia 的股票最近上涨了 6.5%，市值为 50.3 亿美元。该公司报告上个季度每股收益为 0.52 美元，超出预期，收入同比激增 4187.1%。内部人士最近出售了大量股份，显示出所有权可能发生变化</p>

<ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾：12/25 - 12/29</li>
</ul>
</div><p>Liquidia Corporation (NASDAQ:LQDA - Free Report) - Research analysts at HC Wainwright lifted their FY2028 EPS estimates for shares of Liquidia in a note issued to investors on Tuesday, May 12th. HC Wainwright analyst A. Fein now anticipates that the company will earn $6.37 per share for the year, up from their previous forecast of $5.93. HC Wainwright has a &#34;Buy&#34; rating and a $67.00 price objective on the stock. The consensus estimate for Liquidia's current full-year earnings is $2.14 per share. HC Wainwright also issued estimates for Liquidia's FY2030 earnings at $8.36 EPS.</p>
<div class="lb-trans"><p>Liquidia Corporation (NASDAQ:LQDA - 免费报告) - HC Wainwright 的研究分析师在 5 月 12 日向投资者发布的报告中上调了 Liquidia 2028 财年的每股收益（EPS）预期。HC Wainwright 分析师 A. Fein 现在预计该公司将实现每股收益 6.37 美元，高于之前预测的 5.93 美元。HC Wainwright 对该股票给予 &#34;买入&#34; 评级，目标价为 67.00 美元。Liquidia 当前全年的共识收益预期为每股 2.14 美元。HC Wainwright 还对 Liquidia 2030 财年的收益预期为每股 8.36 美元。</p>
</div><p>Other equities research analysts have also recently issued research reports about the stock. Wells Fargo &amp; Company increased their price target on shares of Liquidia from $51.00 to $62.00 and gave the company an &#34;overweight&#34; rating in a research report on Tuesday. Lifesci Capital upgraded shares of Liquidia to a &#34;strong-buy&#34; rating in a report on Thursday, March 5th. Jefferies Financial Group restated a &#34;buy&#34; rating and issued a $60.00 price objective on shares of Liquidia in a report on Monday. Oppenheimer upped their price objective on shares of Liquidia from $16.00 to $19.00 and gave the stock an &#34;underperform&#34; rating in a report on Thursday, March 12th. Finally, Zacks Research upgraded shares of Liquidia from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Tuesday, May 5th. Three investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $49.33.</p>
<div class="lb-trans"><p>其他股票研究分析师最近也发布了关于该股票的研究报告。富国银行将 Liquidia 的目标价从 51.00 美元上调至 62.00 美元，并在周二的研究报告中给予公司 &#34;超配&#34; 评级。Lifesci Capital 在 3 月 5 日的报告中将 Liquidia 的评级上调至 &#34;强力买入&#34;。杰富瑞金融集团在周一的报告中重申了 &#34;买入&#34; 评级，并对 Liquidia 的股票设定了 60.00 美元的目标价。Oppenheimer 在 3 月 12 日的报告中将 Liquidia 的目标价从 16.00 美元上调至 19.00 美元，并给予该股票 &#34;表现不佳&#34; 的评级。最后，Zacks Research 在 5 月 5 日的报告中将 Liquidia 的评级从 &#34;持有&#34; 上调至 &#34;强力买入&#34;。三位投资分析师对该股票给予了强力买入评级，七位给予了买入评级，两位给予了卖出评级。根据 MarketBeat 的数据，该股票目前的平均评级为 &#34;适度买入&#34;，共识目标价为 49.33 美元。</p>
</div><ul>
<li>Liquidia: Court victory the awakening of an industry giant?</li>
</ul>
<div class="lb-trans"><ul>
<li>Liquidia：法院胜利是行业巨头的觉醒？</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Liquidia</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 Liquidia 股票报告</strong></p>
</div><h2>Liquidia Trading Up 6.5%</h2>
<div class="lb-trans"><h2>Liquidia 股价上涨 6.5%</h2>
</div><p>Shares of LQDA opened at $56.60 on Wednesday. The stock has a market capitalization of $5.03 billion, a P/E ratio of 404.31 and a beta of 0.41. The company has a quick ratio of 1.84, a current ratio of 2.01 and a debt-to-equity ratio of 2.97. The firm has a fifty day simple moving average of $38.17 and a two-hundred day simple moving average of $35.29. Liquidia has a twelve month low of $11.85 and a twelve month high of $57.00.</p>
<div class="lb-trans"><p>LQDA 的股票在周三以 56.60 美元开盘。该公司的市值为 50.3 亿美元，市盈率为 404.31，贝塔值为 0.41。该公司的速动比率为 1.84，流动比率为 2.01，债务与股本比率为 2.97。该公司的 50 日简单移动平均为 38.17 美元，200 日简单移动平均为 35.29 美元。Liquidia 的 12 个月低点为 11.85 美元，12 个月高点为 57.00 美元。</p>
</div><p>Liquidia (NASDAQ:LQDA - Get Free Report) last announced its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.41 by $0.11. The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $119.44 million. Liquidia had a net margin of 7.74% and a return on equity of 81.61%. The company's revenue was up 4187.1% compared to the same quarter last year.</p>
<div class="lb-trans"><p>Liquidia (NASDAQ:LQDA - 获取免费报告) 最近在 5 月 11 日公布了季度财报。该公司报告季度每股收益为 0.52 美元，超出共识预期的 0.41 美元，超出幅度为 0.11 美元。该季度的营业收入为 1.3287 亿美元，而分析师预期为 1.1944 亿美元。Liquidia 的净利润率为 7.74%，股本回报率为 81.61%。与去年同期相比，该公司的收入增长了 4187.1%。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Liquidia news, CFO Michael Kaseta sold 139,390 shares of the company's stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $40.14, for a total value of $5,595,114.60. Following the completion of the transaction, the chief financial officer directly owned 353,356 shares in the company, valued at approximately $14,183,709.84. This represents a 28.29% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stephen M. Bloch sold 62,550 shares of the company's stock in a transaction on Friday, March 27th. The stock was sold at an average price of $35.94, for a total transaction of $2,248,047.00. Following the completion of the transaction, the director owned 2,188,935 shares of the company's stock, valued at $78,670,323.90. This trade represents a 2.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 653,820 shares of company stock worth $25,838,508. 25.60% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他 Liquidia 的新闻中，首席财务官 Michael Kaseta 于 4 月 15 日出售了 139,390 股公司的股票。股票以平均价格 40.14 美元出售，总价值为 5,595,114.60 美元。交易完成后，首席财务官直接持有 353,356 股公司的股票，价值约为 14,183,709.84 美元。这代表其持股减少了 28.29%。该出售在向证券交易委员会提交的文件中披露，相关文件可通过 SEC 网站访问。该交易是在预先安排的 10b5-1 交易计划下执行的。此外，董事 Stephen M. Bloch 于 3 月 27 日出售了 62,550 股公司的股票。股票以平均价格 35.94 美元出售，总交易额为 2,248,047.00 美元。交易完成后，该董事持有 2,188,935 股公司的股票，价值 78,670,323.90 美元。此交易代表其持股减少了 2.78%。该出售的 SEC 文件提供了更多信息。在过去的九十天里，内部人士出售了价值 25,838,508 美元的 653,820 股公司股票。当前 25.60% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several institutional investors have recently modified their holdings of LQDA. Farallon Capital Management LLC increased its stake in shares of Liquidia by 102.1% in the 3rd quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company's stock worth $194,783,000 after acquiring an additional 4,326,876 shares in the last quarter. TCG Crossover Management LLC bought a new position in shares of Liquidia in the 3rd quarter worth about $38,887,000. Caprock Group LLC bought a new position in shares of Liquidia in the 3rd quarter worth about $37,114,000. MPM Bioimpact LLC increased its stake in shares of Liquidia by 600.4% in the 4th quarter. MPM Bioimpact LLC now owns 1,400,869 shares of the company's stock worth $48,316,000 after acquiring an additional 1,200,869 shares in the last quarter. Finally, Voloridge Investment Management LLC bought a new position in shares of Liquidia in the 3rd quarter worth about $12,571,000. 64.54% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>几家机构投资者最近调整了对 LQDA 的持股。Farallon Capital Management LLC 在第三季度将其在 Liquidia 的持股增加了 102.1%。Farallon Capital Management LLC 现在拥有 8,565,638 股公司股票，价值 194,783,000 美元，此前在上一季度增持了 4,326,876 股。TCG Crossover Management LLC 在第三季度购买了 Liquidia 的新头寸，价值约 38,887,000 美元。Caprock Group LLC 在第三季度购买了 Liquidia 的新头寸，价值约 37,114,000 美元。MPM Bioimpact LLC 在第四季度将其在 Liquidia 的持股增加了 600.4%。MPM Bioimpact LLC 现在拥有 1,400,869 股公司股票，价值 48,316,000 美元，此前增持了 1,200,869 股。最后，Voloridge Investment Management LLC 在第三季度购买了 Liquidia 的新头寸，价值约 12,571,000 美元。当前 64.54% 的股票由机构投资者持有。</p>
</div><h2>Liquidia News Roundup</h2>
<div class="lb-trans"><h2>Liquidia 新闻汇总</h2>
</div><p>Here are the key news stories impacting Liquidia this week:</p>
<div class="lb-trans"><p>以下是本周影响 Liquidia 的主要新闻故事：</p>
</div><ul>
<li>Positive Sentiment: Liquidia reported a major Q1 beat, with EPS of $0.52 versus $0.41 expected and revenue of $132.87 million versus $119.44 million expected, reinforcing the company’s rapid commercial growth and improving profitability. Earnings report</li>
<li>Positive Sentiment: Management said YUTREPIA net product sales rose 44% sequentially and projected at least $1 billion in net revenue by 2027, signaling strong launch momentum and a long growth runway. Seeking Alpha article</li>
<li>Positive Sentiment: Needham raised its price target to $70 and BTIG lifted its target to $59, both keeping bullish ratings in place, which suggests Wall Street sees more upside after the earnings beat. Needham price target note</li>
<li>Positive Sentiment: Zacks added Liquidia to its Strong Buy list, adding another sentiment boost following the earnings release. Zacks Strong Buy list</li>
<li>Neutral Sentiment: CEO Roger Jeffs sold 25,000 shares in a pre-arranged 10b5-1 plan; while this is worth noting, it appears routine and relatively small versus his remaining stake. SEC filing</li>
<li>Negative Sentiment: One recent downgrade argued that YUTREPIA’s launch momentum may be approaching a ceiling, raising questions about how much additional market-share expansion remains. Seeking Alpha downgrade</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：Liquidia 报告了第一季度的重大超预期，每股收益为 0.52 美元，预期为 0.41 美元，收入为 1.3287 亿美元，预期为 1.1944 亿美元，进一步巩固了公司的快速商业增长和改善的盈利能力。财报</li>
<li>积极情绪：管理层表示 YUTREPIA 的净产品销售环比增长 44%，预计到 2027 年净收入至少达到 10 亿美元，显示出强劲的上市势头和长期的增长潜力。Seeking Alpha 文章</li>
<li>积极情绪：Needham 将其目标价上调至 70 美元，BTIG 将其目标价上调至 59 美元，均维持看涨评级，这表明华尔街在财报超预期后看到了更多的上涨空间。Needham 目标价说明</li>
<li>积极情绪：Zacks 将 Liquidia 纳入其强力买入名单，在财报发布后又增加了一次情绪提振。Zacks 强力买入名单</li>
<li>中性情绪：首席执行官 Roger Jeffs 在一项预先安排的 10b5-1 计划中出售了 25,000 股；虽然这值得注意，但与他剩余的股份相比，这似乎是例行的且相对较小。SEC 文件</li>
<li>消极情绪：最近的一次评级下调认为 YUTREPIA 的上市势头可能接近天花板，提出了关于市场份额扩展还有多少的疑问。Seeking Alpha 下调</li>
</ul>
</div><h2>Liquidia Company Profile</h2>
<div class="lb-trans"><h2>Liquidia 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.</p>
<div class="lb-trans"><p>Liquidia Technologies, Inc 是一家临床阶段的生物制药公司，总部位于北卡罗来纳州的研究三角园区。该公司利用其专有的 PRINT®（非湿润模板中的颗粒复制）平台来工程化精确形状和尺寸的药物颗粒，旨在改善药物的递送、疗效和安全性。通过控制纳米尺度的颗粒特性，Liquidia 力求增强依赖于靶向递送的呼吸和其他疗法。</p>
</div><p>The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).</p>
<div class="lb-trans"><p>该公司的主要产品候选药物 LIQ861 是一种干粉配方的特雷普利斯汀，旨在用于治疗肺动脉高压（PAH）患者的吸入。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Liquidia</li>
<li>A Real Biggie Deal: Wendy's Serves Up a Juicy Buyout Arbitrage</li>
<li>Ally Financial Is Back to Basics—And Investors Are Watching</li>
<li>Navitas Breaks Out on India Deal, Validating High-Power AI Pivot</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票</li>
<li>一笔真正的大交易：温迪汉堡推出丰厚的收购套利</li>
<li>Ally Financial 回归基础——投资者在关注</li>
<li>Navitas 在印度交易中突破，验证高功率 AI 转型</li>
<li>海军催化剂点燃 Odysight 的增长引擎</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFFEQQ" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=LQDA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Liquidia Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Liquidia 吗？</h2>
</div><p>Before you consider Liquidia, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Liquidia 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Liquidia wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄推荐给客户的股票，建议在更广泛的市场注意到之前购买……而 Liquidia 并不在名单上。</p>
</div><p>While Liquidia currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Liquidia 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

HC Wainwright 上调了 Liquidia 2028 财年的每股收益预估